Aprepitant, a novel neurokinin-1 receptor antagonist in management of chemotherapy induces nausea vomiting (CINV) in cancer patients. Int J Res Pharm Hos & Clin. Pharm [Internet]. 2019 Sep. 14 [cited 2025 Apr. 19];2(1):1-4. Available from: https://rubatosis.org/journals/index.php/ijrhcp/article/view/144